All charts and data below are CPI-U inflation-adjusted and with dividends reinvested. (Why?)
NVO real return snapshot: after CPI-U inflation, NVO returned −27.37% over the past year and −0.99% YTD, with dividends reinvested. Since Apr. 30, 1981, NVO is up +15,843.68% in real purchasing-power return, or +11.88%/yr, and is currently −65.71% below its real total-return high on Jun. 25, 2024.
Data ending Thu Jul. 2, 2026
| Thu 1981-04-30💬 to Thu 2026-07-02 |
YTD
Return |
1 Year
Return |
||||
|---|---|---|---|---|---|---|
| NVO × |
−0.99%
2026-07-02 |
−27.37%
2026-07-02 |
||||
| Novo Nordisk A/S NYSE Common Stock | ||||||
| Thu 1981-04-30💬 to Thu 2026-07-02 |
Overall
Return |
Exponential
Trendline |
||||
|---|---|---|---|---|---|---|
| NVO × |
+15,843.68%
+11.88%/yr |
+15.44%/yr
(R2=0.961) |
||||
| Novo Nordisk A/S NYSE Common Stock | ||||||
| Thu 1981-04-30💬 to Thu 2026-07-02 |
Start
Value |
End
Value |
||||
|---|---|---|---|---|---|---|
| NVO × |
$10,000.00
1981-04-30 |
$1,594,367.81
2026-07-02 |
||||
| Novo Nordisk A/S NYSE Common Stock | ||||||
| Year | NVO |
|---|---|
| 2026 (YTD) | −0.99% |
| 2025 | −40.80% |
| 2024 | −18.29% |
| 2023 | +49.82% |
| 2022 | +15.21% |
| 2021 | +52.77% |
| 2020 | +21.68% |
| 2019 | +25.83% |
| 2018 | −13.76% |
| 2017 | +51.03% |
| 2016 | −37.85% |
| 2015 | +38.38% |
| 2014 | +15.79% |
| 2013 | +13.70% |
| 2012 | +41.63% |
| 2011 | +0.92% |
| 2010 | +76.85% |
| 2009 | +23.62% |
| 2008 | −19.80% |
| 2007 | +51.19% |
| 2006 | +47.34% |
| 2005 | +1.78% |
| 2004 | +30.39% |
| 2003 | +41.30% |
| 2002 | −28.92% |
| 2001 | +12.46% |
| 2000 | +34.20% |
| 1999 | −4.58% |
| 1998 | −8.81% |
| 1997 | +52.53% |
| 1996 | +33.74% |
| 1995 | +41.82% |
| 1994 | −6.05% |
| 1993 | +9.20% |
| 1992 | −2.93% |
| 1991 | +40.34% |
| 1990 | +18.95% |
| 1989 | +24.97% |
| 1988 | +76.65% |
| 1987 | −36.99% |
| 1986 | +11.73% |
| 1985 | +20.54% |
| 1984 | −59.00% |
| 1983 | +23.66% |
| 1982 | +6.09% |
| 1981 | +18.09% |
| Thu 1981-04-30💬 to Thu 2026-07-02 |
Current
Drawdown |
Worst
Drawdown |
||||
|---|---|---|---|---|---|---|
| NVO × |
−65.71%
from 2024-06-25 peak |
−75.89%
2026-03-27 from 2024-06-25 peak |
||||
| Novo Nordisk A/S NYSE Common Stock | ||||||
| Period ending Thu 2026-07-02 |
1
Year |
2
Years |
3
Years |
5
Years |
10
Years |
|
|---|---|---|---|---|---|---|
| NVO × | −27.37% |
−64.77% −40.64%/yr |
−38.81% −15.10%/yr |
+6.99% +1.36%/yr |
+67.69% +5.31%/yr |
|
| Novo Nordisk A/S NYSE Common Stock | ||||||
